Related Experiment Video
Updated: Sep 9, 2025
Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Salmon Nasal Cartilage-Derived Proteoglycans Alleviate Cartilage Degeneration in Osteoarthritis by Modulating
Jinhee Kim1, Jeongjin Park2, Seong-Hoo Park1
1Clinical Nutrition Institute, Kyung Hee University, Seoul, Republic of Korea.
Abstract:
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by progressive cartilage damage, inflammatory responses, and apoptosis of chondrocytes. In this study, we investigated the therapeutic potential properties of proteoglycans (PG) extracted from salmon nasal cartilage in both in vitro (HTB-94 human chondrocytic cells) and in vivo (monosodium iodoacetate-induced OA rat model) approaches. Rats were treated with PG, and key parameters related to cartilage integrity, inflammation, and apoptosis were evaluated. Our results showed that PG treatment significantly improved cartilage structure and decreased inflammation, as evidenced by decreased levels of PGE2 and nitric oxide, as well as reduced expression of pro-inflammatory cytokines, including tumor necrosis factor-alpha, interleukin-1β, and interleukin-6. PG also downregulated matrix metalloproteinases while increasing tissue inhibitors of metalloproteinases, preserving cartilage integrity. Additionally, apoptotic signaling pathways including JNK/c-Fos/c-Jun and FADD/capase-8/caspase-3 were attenuated, and the Bax/Bcl-2 ratio was favorably modulated by PG. These findings suggest that PG can protect articular cartilage by mitigating inflammation, preserving cartilage degradation, and preventing chondrocyte apoptosis. This study supports the potential therapeutic role of PG as a promising treatment option for OA, providing both anti-inflammatory and chondroprotective effects.
Insights
Salmon nasal cartilage proteoglycans (PG) show therapeutic potential for osteoarthritis (OA). PG treatment improved cartilage structure, reduced inflammation, and prevented chondrocyte apoptosis in vitro and in vivo models.
Area of Science:
- Biochemistry
- Pharmacology
- Biomaterials Science
Background:
- Osteoarthritis (OA) is a degenerative joint disease marked by cartilage damage, inflammation, and chondrocyte apoptosis.
- Current OA treatments offer limited efficacy in halting disease progression.
- Proteoglycans (PG) from natural sources are being explored for their therapeutic potential.
Purpose of the Study:
- To investigate the therapeutic effects of proteoglycans (PG) from salmon nasal cartilage on osteoarthritis.
- To evaluate PG's impact on cartilage integrity, inflammation, and chondrocyte apoptosis in vitro and in vivo.
Main Methods:
- In vitro study using HTB-94 human chondrocytic cells.
- In vivo study using a monosodium iodoacetate-induced OA rat model.
- Evaluation of cartilage structure, inflammatory markers (PGE2, nitric oxide, cytokines), matrix metalloproteinases, tissue inhibitors of metalloproteinases, and apoptotic pathways.
Main Results:
- PG treatment significantly improved cartilage structure and reduced inflammation.
- Decreased levels of PGE2, nitric oxide, and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) were observed.
- PG downregulated matrix metalloproteinases, upregulated tissue inhibitors of metalloproteinases, and attenuated apoptotic signaling pathways, favorably modulating the Bax/Bcl-2 ratio.
Conclusions:
- Salmon nasal cartilage PG demonstrates significant anti-inflammatory and chondroprotective effects.
- PG protects articular cartilage by mitigating inflammation, preserving it from degradation, and preventing chondrocyte apoptosis.
- PG represents a promising therapeutic agent for osteoarthritis management.
Related Concept Videos
01:23Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
01:05Proteoglycans